Stages I-IIIA Lung Cancer – Non-Small Cell

Preoperative Chemotherapy Improves Survival in NSCLC (05-2-2014)

Pre-operative (neoadjuvant) chemotherapy for non-small cell lung cancer (NSCLC) is associated with a significant reduction in the risk of death, according to the results of a meta-analysis published in The Lancet. Lung cancer remains the leading cause... Continue Reading

Standard Dose of Radiation Therapy Outperforms Higher Dose for Advanced Non-Small Cell Lung Cancer (06-12-2013)

In a phase III clinical trial, a standard dose of radiation therapy was more effective than a higher dose for the treatment of stage III non-small cell lung cancer (NSCLC). These results will be presented at the 49th Annual Meeting of the American Society... Continue Reading

Stereotactic Body Radiation Improves Lung Cancer Survival (11-9-2012)

Stereotactic body radiation for early-stage, inoperable non-small cell lung cancer yields high overall survival rates and low toxicity compared to conventional radiotherapy, according to the results of a study presented at the annual meeting of the American... Continue Reading

Genetic Study Identifies New Targets for Treating Squamous Cell Lung Cancer (09-19-2012)

Researchers have identified a large variety of genetic alterations that appear to be responsible for the development and growth of squamous cell lung cancer, according to the results of a study published in Nature. The discovery could lead to new targeted... Continue Reading

Some Lung Cancer Patients Receive Potentially Unhelpful Treatment (03-2-2012)

Among older patients who undergo surgery for locally advanced, non-small-cell lung cancer, many receive postoperative radiation therapy. The radiation therapy, however, may not improve treatment outcomes. These results were published in Cancer. Lung cancer... Continue Reading

Higher Radiation Dose Does Not Benefit Lung Cancer Patients (10-13-2011)

Among patients with Stage III non-small cell lung cancer, treatment with a higher dose of radiation therapy does not result in better overall survival than a standard dose of radiation therapy. These results were presented at the 53rd Annual Meeting of... Continue Reading

Elderly, Minorities and Women Under-represented in Lung Cancer Clinical Trials (08-25-2011)

Compared with the demographics of lung cancer in the United States, the elderly, minorities, and women remain vastly under-represented in lung cancer clinical trials. These results were presented at the 14th World Conference on Lung Cancer. Clinical trials... Continue Reading

Genetic Assay Predicts Survival in Early Non-small Cell Lung Cancer (08-17-2011)

A genetic test performed on a sample of tumor tissue helps predict survival among patients with early, non-squamous, non-small cell lung cancer (NSCLC) who are treated with surgery only. Patients with low predicted survival may benefit from the addition... Continue Reading

Lung CT Scans Produce Variable Results (07-13-2011)

Estimates of lung tumor size based on computed tomography (CT) scans can vary from scan to scan even when the actual size of the tumor remains the same. These results were published in the Journal of Clinical Oncology. CT scans are used for imaging body... Continue Reading

Liposomal Cisplatin Safe for Patients with Renal Insufficiency (06-14-2011)

Liposomal cisplatin (Nanoplatin®), a chemotherapy drug still in clinical trials, does not cause damage to the kidneys and appears to provide at least equal anti-cancer effects as cisplatin (Platinol®) among cancer patients with renal insufficiency.... Continue Reading

« Previous PageNext Page »